{
  "@context": "aku-v2",
  "@type": "definition",
  "@id": "vascular:tos:neurogenic:definition",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T17:57:00.000Z",
    "contributors": [
      "copilot"
    ],
    "status": "enhanced",
    "confidence": 0.92,
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/tos",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "specialized",
    "board_yield": "MODERATE"
  },
  "content": {
    "term": "Neurogenic Thoracic Outlet Syndrome",
    "synonyms": [
      "Neurogenic TOS",
      "Brachial Plexus Compression Syndrome",
      "True vs Disputed Neurogenic TOS"
    ],
    "definition": "Compression of the brachial plexus in the thoracic outlet, causing upper extremity pain, paresthesias, and weakness. Neurogenic TOS is the most common form (95% of TOS cases) but is often controversial due to lack of objective findings in many patients.",
    "classification": {
      "true_neurogenic_tos": {
        "definition": "Objective neurologic findings with EMG abnormalities",
        "frequency": "Rare (<1% of TOS)",
        "features": [
          "Cervical rib usually present",
          "Hand intrinsic muscle atrophy (Gilliatt-Sumner hand)",
          "EMG abnormalities (C8-T1 distribution)",
          "Sensory loss in ulnar distribution"
        ]
      },
      "disputed_neurogenic_tos": {
        "definition": "Symptoms suggestive of TOS without objective findings",
        "frequency": "Most common (>95% of neurogenic TOS)",
        "features": [
          "Pain and paresthesias",
          "No objective EMG findings",
          "Normal physical examination or subtle findings",
          "Controversial diagnosis"
        ]
      }
    },
    "anatomy": {
      "compression_sites": [
        "Interscalene triangle (between anterior and middle scalene)",
        "Costoclavicular space",
        "Subcoracoid space (under pectoralis minor)"
      ],
      "brachial_plexus_involvement": [
        "Lower trunk (C8-T1) most commonly affected",
        "Upper trunk less commonly"
      ]
    },
    "clinical_features": {
      "symptoms": [
        "Pain in neck, shoulder, arm (most common)",
        "Paresthesias (numbness, tingling) in arm/hand",
        "Weakness (less common)",
        "Symptoms worse with arm elevation"
      ],
      "true_neurogenic_findings": [
        "Gilliatt-Sumner hand (thenar > hypothenar atrophy)",
        "Intrinsic hand muscle weakness",
        "Sensory loss ulnar forearm/hand"
      ],
      "provocative_tests": [
        "Adson test (limited specificity)",
        "Roos test (3 minutes of elevated arm exercise)",
        "Wright hyperabduction test",
        "Costoclavicular maneuver"
      ]
    },
    "diagnosis": {
      "clinical": "Based on symptoms and provocative tests",
      "imaging": [
        "Chest X-ray (cervical rib)",
        "MRI of brachial plexus",
        "CTA/MRA if vascular component suspected"
      ],
      "electrodiagnostic": [
        "EMG/NCS for true neurogenic TOS",
        "Medial antebrachial cutaneous nerve conduction",
        "Often normal in disputed neurogenic TOS"
      ],
      "diagnostic_blocks": [
        "Scalene muscle block with local anesthetic",
        "Temporary relief suggests TOS",
        "Helps predict surgical success"
      ]
    },
    "differential_diagnosis": [
      "Cervical radiculopathy",
      "Carpal tunnel syndrome",
      "Ulnar neuropathy at elbow",
      "Rotator cuff disease",
      "Fibromyalgia",
      "Brachial plexitis (Parsonage-Turner)"
    ],
    "treatment": {
      "conservative_first": [
        "Physical therapy (postural training, strengthening)",
        "NSAIDs",
        "Muscle relaxants",
        "Scalene/botulinum injections"
      ],
      "surgery_indications": [
        "True neurogenic TOS (atrophy, EMG changes)",
        "Failed conservative therapy (3-6 months)",
        "Positive scalene block response",
        "Significant functional impairment"
      ],
      "surgical_options": [
        "Transaxillary first rib resection",
        "Supraclavicular approach with scalenectomy",
        "Combined approach for complex cases"
      ]
    },
    "outcomes": {
      "true_neurogenic": "Good outcomes with surgery (80-90%)",
      "disputed_neurogenic": "Variable outcomes (60-70% improvement)",
      "factors": [
        "Patient selection critical",
        "Positive scalene block predicts success",
        "Workers compensation claims have worse outcomes"
      ]
    },
    "statement": "vascular:tos:neurogenic:definition is a fundamental concept in Health-Sciences Medicine Surgery Vascular Tos that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding vascular:tos:neurogenic:definition helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of vascular:tos:neurogenic:definition include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of vascular:tos:neurogenic:definition."
    }
  },
  "codes": {
    "snomed_ct": "89585001",
    "icd_10": "G54.0"
  },
  "relationships": {
    "broader": [
      "vascular:tos"
    ],
    "related": [
      "vascular:tos:arterial",
      "vascular:tos:venous"
    ],
    "narrower": []
  },
  "pedagogical": {
    "learning_objectives": [
      "Distinguish true vs disputed neurogenic TOS",
      "Know Gilliatt-Sumner hand presentation",
      "Understand the importance of patient selection for surgery"
    ],
    "clinical_pearls": [
      "Neurogenic TOS is 95% of TOS but most is 'disputed' without objective findings",
      "TRUE neurogenic TOS: cervical rib + Gilliatt-Sumner hand + EMG changes",
      "Gilliatt-Sumner hand = thenar > hypothenar atrophy",
      "Positive scalene block predicts surgical success",
      "Conservative therapy first for disputed TOS (3-6 months)"
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). vascular:tos:neurogenic:definition. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}